334 related articles for article (PubMed ID: 15447768)
21. Emergence of the precore mutant late in chronic hepatitis B infection correlates with the severity of liver injury and mutations in the core region.
Maruyama T; Mitsui H; Maekawa H; Yamada H; Hirayama M; Iino S; Yasuda K; Koike K; Kimura S; Milich DR
Am J Gastroenterol; 2000 Oct; 95(10):2894-904. PubMed ID: 11051365
[TBL] [Abstract][Full Text] [Related]
22. Clinical relevance of HBV DNA load in patients with chronic hepatitis B infection.
Madan K; Batra Y; Jha JK; Kumar S; Kalra N; Paul SB; Singh R; Duttagupta S; Panda SK; Acharya SK
Trop Gastroenterol; 2008; 29(2):84-90. PubMed ID: 18972767
[TBL] [Abstract][Full Text] [Related]
23. Markers of disease activity in chronic hepatitis B virus infection.
Yalcin K; Degertekin H; Yildiz F; Celik Y
Clin Invest Med; 2003 Feb; 26(1):27-34. PubMed ID: 12659467
[TBL] [Abstract][Full Text] [Related]
24. Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients.
Wong DK; Yuen MF; Yuan H; Sum SS; Hui CK; Hall J; Lai CL
Hepatology; 2004 Sep; 40(3):727-37. PubMed ID: 15349913
[TBL] [Abstract][Full Text] [Related]
25. HBV-DNA levels in HBsAg-positive blood donors and its relationship with liver histology.
Nabuco LC; Villela-Nogueira CA; Perez RM; Ceci L; Pannain VL; Nogueira CM; Segadas-Soares JA; Coelho HS
J Clin Gastroenterol; 2007 Feb; 41(2):194-8. PubMed ID: 17245219
[TBL] [Abstract][Full Text] [Related]
26. Chronic HBV infection. Immunomodulation with levamisole in viremic HBeAg positive or anti-HBe positive patients--a pilot study.
Krastev Z; Jelev D; Antonov K; Alagozian V; Kotzev I
Hepatogastroenterology; 1999; 46(30):3184-8. PubMed ID: 10626183
[TBL] [Abstract][Full Text] [Related]
27. Chronic carriers of hepatitis B virus in Bangladesh: a comparative analysis of HBV-DNA, HBeAg/anti-HBe, and liver function tests.
Hasan KN; Rumi MA; Hasanat MA; Azam MG; Ahmed S; Salam MA; Islam LN; Hassan MS
Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):110-7. PubMed ID: 12118438
[TBL] [Abstract][Full Text] [Related]
28. Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection.
Manesis EK; Papatheodoridis GV; Sevastianos V; Cholongitas E; Papaioannou C; Hadziyannis SJ
Am J Gastroenterol; 2003 Oct; 98(10):2261-7. PubMed ID: 14572577
[TBL] [Abstract][Full Text] [Related]
29. Combination of baseline parameters and on-treatment hepatitis B virus DNA levels to start and continue patients with lamivudine therapy.
Yuen MF; Fung J; Seto WK; Wong DK; Yuen JC; Lai CL
Antivir Ther; 2009; 14(5):679-85. PubMed ID: 19704171
[TBL] [Abstract][Full Text] [Related]
30. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
[TBL] [Abstract][Full Text] [Related]
31. Presence of hepatitis B virus core promoter mutations pre-seroconversion predict persistent viral replication after HBeAg loss.
Ferns RB; Naoumov NV; Gilson RJ; Tedder RS
J Clin Virol; 2007 Jul; 39(3):199-204. PubMed ID: 17526429
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis B virus genotypes and G1896A precore mutation in 486 Spanish patients with acute and chronic HBV infection.
Rodriguez-Frias F; Jardi R; Buti M; Schaper M; Hermosilla E; Valdes A; Allende H; Martell M; Esteban R; Guardia J
J Viral Hepat; 2006 May; 13(5):343-50. PubMed ID: 16637866
[TBL] [Abstract][Full Text] [Related]
33. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India.
Shanmugam S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Shankar EM; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
J Microbiol Biotechnol; 2008 Oct; 18(10):1722-8. PubMed ID: 18955826
[TBL] [Abstract][Full Text] [Related]
34. Serial HBV DNA levels in patients with persistently normal transaminase over 10 years following spontaneous HBeAg seroconversion.
Chen YC; Huang SF; Chu CM; Liaw YF
J Viral Hepat; 2012 Feb; 19(2):138-46. PubMed ID: 22239503
[TBL] [Abstract][Full Text] [Related]
35. Low HBV-DNA levels in end-stage renal disease patients with HBeAg-negative chronic hepatitis B.
Moutinho RS; Perez RM; Medina-Pestana JO; Figueiredo MS; Koide S; Alberto FL; Silva AE; Ferraz ML
J Med Virol; 2006 Oct; 78(10):1284-8. PubMed ID: 16927290
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
Chen CH; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
Liver Int; 2007 Aug; 27(6):806-15. PubMed ID: 17617124
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of normal or minimally elevated alanine transaminase, age and DNA level in predicting liver histological changes in chronic hepatitis B.
Alam S; Ahmad N; Mustafa G; Shrestha A; Alam AK; Khan M
Liver Int; 2011 Jul; 31(6):824-30. PubMed ID: 21645213
[TBL] [Abstract][Full Text] [Related]
38. There were no differences in serum HBV DNA level between HBeAg-positive and HBeAg-negative chronic hepatitis B with same liver histological necroinflammation grade but differences among grades 1, 2, 3 and 4 apportioned by the same hepatic parenchyma cell volume.
Ke WM; Xie SB; Li XJ; Zhang SQ; Lai J; Ye YN; Gao ZL; Chen PJ
J Viral Hepat; 2011 Sep; 18(9):637-45. PubMed ID: 21794025
[TBL] [Abstract][Full Text] [Related]
39. Profile of chronic hepatitis B virus in children in India: experience with 116 children.
Satapathy SK; Garg S; Chauhan R; Malhotra V; Sakhuja P; Sharma BC; Sarin SK
J Gastroenterol Hepatol; 2006 Jul; 21(7):1170-6. PubMed ID: 16824071
[TBL] [Abstract][Full Text] [Related]
40. Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project).
Zacharakis GH; Koskinas J; Kotsiou S; Papoutselis M; Tzara F; Vafeiadis N; Archimandritis AJ; Papoutselis K
J Med Virol; 2005 Oct; 77(2):173-9. PubMed ID: 16121378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
